Showing results (141-150 of 206) with videos related to
Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry|January 17, 2017
Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of conceptVictoria Calzada, María Moreno, Jessica Newton, et al.Chemical Reviews|February 21, 2024
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging PharmacologyR Justin Grams, Webster L Santos, Ion Romulus Scorei, et al.Inflammation & Allergy Drug Targets|October 23, 2015
Analgesic and Anti-Inflammatory Properties of ArylnitroalkenesLaura Celano, Yolanda K Cupertino Da Silva, Nicolás Cataldo, et al.Journal of Inorganic Biochemistry|September 7, 2007
New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agentsCarolina Urquiola, Dinorah Gambino, Mauricio Cabrera, et al.Journal of Inorganic Biochemistry|February 4, 2009
Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activityMarisol Vieites, Lucía Otero, Diego Santos, et al.Biochemistry|March 22, 2007
Synthesis, isomer characterization, and anti-inflammatory properties of nitroarachidonateAndrés Trostchansky, José M Souza, Ana Ferreira, et al.Bioorganic & Medicinal Chemistry|November 11, 2009
New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studiesJorge Rodríguez, Vicente J Arán, Lucía Boiani, et al.Chemmedchem|March 16, 2026
Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid CarcinomaMarcos Couto, Martina Buschittari, Marina Carpano, et al.Molecules (Basel, Switzerland)|June 26, 2009
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugsSaioa Ancizu, Elsa Moreno, Enrique Torres, et al.Toxicology Letters|July 15, 2009
Cytotoxic, mutagenic and genotoxic effects of new anti-T. cruzi 5-phenylethenylbenzofuroxans. Contribution of phase I metabolites on the mutagenicity inductionMauricio Cabrera, María Laura Lavaggi, Paola Hernández, et al.Pageof 21